IP Library › Assignment 058713/0014
Patent Assignment
Reel/Frame 058713/0014

Assignment of Assignor's Interest

Recorded: 2022-01-20 Pages: 8
Assignors
RAE, ALASTAIR
Executed: 2019-04-24
ELLARD, JOHN MARK
Executed: 2019-04-24
Assignee
CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
CHESTERFORD RESEARCH PARK, SAFFRON WALDEN, ROBINSON BUILDING, ESSEX, CB10 1XL, UNITED KINGDOM
Covered Property (1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Application: 16/908,497 →
Publication: US 2020/0317667
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 23, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056957/0356 →
Assignment of Assignor's Interest Jan 20, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 058712/0889 →
Assignment of Assignor's Interest Jan 20, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058712/0905 →
Assignment of Assignor's Interest Jan 20, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058712/0920 →
Assignment of Assignor's Interest Jan 20, 2022
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058713/0029 →
Assignment of Assignor's Interest Jan 20, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058713/0041 →